Synopsis of recent research by authors named "Alena Skrahina"
- Alena Skrahina's recent research primarily focuses on innovative strategies for improving treatment adherence and outcomes for multidrug-resistant tuberculosis (MDR-TB) among vulnerable populations, including individuals with alcohol use disorders and those co-infected with HIV.
- Her studies investigate the effectiveness and safety of novel shortened treatment regimens for rifampicin-resistant tuberculosis, employing person-centred care approaches and advanced analytical techniques such as machine learning for resistance profiling.
- Skrahina also emphasizes the importance of diagnostic advancements, such as the comparison of molecular testing methodologies, and the long-term health outcomes of patients facing dual challenges from TB and COVID-19, thereby contributing to a deeper understanding of co-morbid conditions in public health contexts.
